In a secondary mixed-methods analysis of 20 participants given 25 mg psilocybin in the PAD trial for alcohol use disorder with depressive symptoms, 3-month abstinence was associated with integration-session talk of inner dialogue and adaptive coping.
Secondary analysisn = 20
Garcia Garcia et al. Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms